While sifting through the bacterial genome of salmonella, Cornell food scientists discovered mcr-9, a new, stealthy jumping gene so diabolical and robust that it resists one of the world’s few last-resort antibiotics.
Doctors deploy the antibiotic colistin when all other infection-fighting options are exhausted. But resistance to colistin has emerged around the globe, threatening its efficacy.
“This last-resort antibiotic has been designated a highest-priority antibiotic by the United Nations’ World Health Organization, and the mcr-9 gene causes bacteria to resist it,” said Martin Wiedmann, Cornell’s Gellert Family Professor in Food Safety and senior author on the study published May 7 in the journal Mbio. “In treatments, if colistin does not work, it literally could mean death for patients. If colistin resistance spreads, a lot of people will die.”
Co-lead author Laura Carroll, a computational biologist and Cornell doctoral candidate, found mcr-9 in the genome of a strain of foodborne pathogen salmonella.
Because the DNA sequence of the mcr-9 gene was similar to other genes that could cause bacteria to resist colistin, she suspected that the salmonella strain which carried mcr-9 was colistin-resistant. To her surprise, the salmonellastrain failed to show colistin resistance.
Knowing that the mcr-9 gene could jump to other bacteria or organisms, her colleague, senior research associate Ahmed Gaballa, a microbiologist and co-lead author, inserted the gene into a nonpathogenic strain of the bacterium E. coli. Gaballa was able to “turn on” mcr-9, making the E. coli strain resistant to colistin. That showed Carroll was initially correct.
“When we originally tested the salmonella isolate and found that it wasn’t resistant to colistin, we were perplexed,” Carroll said. “But when Ahmed cloned it into an E. coli host, he was able to find that the gene could confer resistance to colistin.”
Mcr-9 is the latest in this new series of “mobilized colistin-resistance” genes – originally discovered in 2015. The National Center for Biotechnology Information, part of the National Institutes of Health, has added details about this new gene to its database. Medical professionals and others can now use this information to identify mcr-9 in bacteria isolated from food products and people.
Details about mcr-9 in national and international databases enable scientists to develop better prevention and treatment, explained Wiedmann. “This improves our ability to get an early warning,” he said.
Bacteria isolated from food products can now be tested for mcr-9, and patients can be screened for colistin-resistant bacteria which possess mcr-9. “If you go to a hospital and this gene is floating around, that can be trouble. The gene is moveable. It jumps,” Wiedmann said.
“In a hospital setting, being able to screen a patient for resistance allows doctors and nurses to isolate the patient and maintain biosecurity.”
Wiedmann pointed out that while his lab is dedicated to food safety, the collaboration of scientists from different fields made the discovery possible. “In this age of complicated problems, we need the computational bioinformatics approach to find solutions,” he said. “Standard biological research and standard tests would not necessarily have found this gene.”
Carroll added: “It takes a village of a computational biologist, a microbiologist and a molecular biologist to make this sort of scientific discovery happen.”
The Latest on: Last-resort antibiotics
via Google News
The Latest on: Last-resort antibiotics
- End of the golden age of antibiotics, which has become a 'truly global issue'on March 2, 2021 at 4:00 pm
They are now the commonest cause of hospital acquired infection and some are becoming resistant to carbapenems, a powerful, last resort group of antibiotics. There has also been an alarming ...
- 'Antibiotics useless in 12 years'on February 28, 2021 at 4:00 pm
The superbug resists almost all antibiotics and there are indications that even vancomycin - until now the powerful drug of last resort - is unable to defeat it. The crisis could assume the same ...
- Antibiotic-Resistance-Screening Diagnostic Wins CE Markon February 25, 2021 at 4:00 pm
CPE are bacteria that are resistant to the carbapenem class of antibiotics, and early detection could help ... which the company said is considered the drug of last resort for many infections. The ...
- Potentially dangerous antibioticson February 19, 2021 at 2:58 pm
Melissa Christian is a family nurse practitioner. She considers Fluroquinolone antibiotics as last resort drugs. “I think I wrote Levaquin twice in the last three years, I don’t write the drug ...
- Wide differences in antibiotic use between countries, says new data from WHOon February 18, 2021 at 7:22 pm
“Reserve” group antibiotics, which should only be used as last-resort antibiotics for treatment of specific infections caused by multidrug-resistant bacteria, account for less than 2% of total ...
- Once invincible superbug squashed by ‘superteam’ of antibioticson February 18, 2021 at 4:00 pm
BUFFALO, N.Y. – The golden age of antibiotics may be drawing to a close. The recent discovery of E. coli carrying mcr-1 and ndm-5 — genes that make the bacterium immune to last-resort antibiotics — ...
- Acquisition of Antibiotic-Resistant Bacteria by U.S. International Travelerson February 17, 2021 at 4:00 pm
because these antibiotics are last-resort treatments for highly antibiotic-resistant gram-negative organisms. Table 1. Table 1. Characteristics of Travelers with Highly Antibiotic-Resistant Bacteria.
- The next pandemic? It may already be upon uson February 15, 2021 at 5:47 am
Neonatal sepsis or blood infection in south Asia is increasingly untreatable – meaning even so-called “last resort” antibiotics don’t work against it – and it is threatening to reverse ...
- Biden must act quickly to defeat another pandemicon February 14, 2021 at 1:22 pm
Right now, new antibiotics are used as last-resort treatments, kept on the shelf instead of saving patients. This caution makes complete sense from a medical perspective, since it helps prevent ...
- Scientists Are Looking Beyond Antibiotics to Stop the Drug-Resistant Bacteria Crisison February 3, 2021 at 4:46 pm
“Their shelf life is so short because of multidrug resistance, and the WHO says we should be saving new antibiotics for last resort, so why would you want to invest a billion dollars and 10 to ...
via Bing News